Agios Pharmaceuticals Inc. (AGIO) poses a Brand-New Opportunity for Investors with beta value of 1.00


Agios Pharmaceuticals Inc. (NASDAQ: AGIO) established initial surge of 0.56% at $28.83, as the Stock market unbolted on November 23, 2022. During the day, the stock rose to $29.06 and sunk to $28.165 before settling in for the price of $28.67 at the close. Taking a more long-term approach, AGIO posted a 52-week range of $16.75-$37.71.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Meanwhile, its Annual Earning per share during the time was -3.10%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -23.60%. This publicly-traded company’s shares outstanding now amounts to $54.84 million, simultaneously with a float of $54.23 million. The organization now has a market capitalization sitting at $1.61 billion. At the time of writing, stock’s 50-day Moving Average stood at $28.31, while the 200-day Moving Average is $26.25.

Agios Pharmaceuticals Inc. (AGIO) Ownership Facts and Figures

Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Agios Pharmaceuticals Inc. industry. According to the most recent insider trade that took place on Feb 25, this organization’s Principal Accounting Officer sold 108 shares at the rate of 30.00, making the entire transaction reach 3,240 in total value, affecting insider ownership by 2,549. Preceding that transaction, on Feb 16, Company’s Principal Accounting Officer sold 233 for 30.81, making the whole transaction’s value amount to 7,179. This particular insider is now the holder of 2,549 in total.

Agios Pharmaceuticals Inc. (AGIO) Earnings and Revenue Records

Going through the last 3-months fiscal report unveiled on the 6/29/2022, it has been observed that the corporation posted -$1.68 earnings per share (EPS) during the time that was better the consensus figure (set at -$1.75) by $0.07. This company achieved a return on equity of -42.15. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.74 per share during the current fiscal year.

Agios Pharmaceuticals Inc.’s EPS decrease for this current 12-month fiscal period is -23.60% and is forecasted to reach -6.77 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 39.00% through the next 5 years, which can be compared against the -3.10% growth it accomplished over the previous five years trading on the market.

Agios Pharmaceuticals Inc. (NASDAQ: AGIO) Trading Performance Indicators

Let’s observe the current performance indicators for Agios Pharmaceuticals Inc. (AGIO). It’s Quick Ratio in the last reported quarter now stands at 14.50. The Stock has managed to achieve an average true range (ATR) of 1.58. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 162.18.

In the same vein, AGIO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -6.72, a figure that is expected to reach -1.65 in the next quarter, and analysts are predicting that it will be -6.77 at the market close of one year from today.

Technical Analysis of Agios Pharmaceuticals Inc. (AGIO)

Now, what If we examine the latest scores posted by [Agios Pharmaceuticals Inc., AGIO]. During the last 5-days, its volume was lower the volume of 0.64 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 69.40% While, its Average True Range was 1.50.


Please enter your comment!
Please enter your name here